157 related articles for article (PubMed ID: 25264324)
41. Gastric acid suppressants--too much of a good thing?
Logan IC; Sumukadas D; Witham MD
Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
[No Abstract] [Full Text] [Related]
42. Anti-acid treatment for idiopathic pulmonary fibrosis.
Tzouvelekis A; Bouros D
Lancet Respir Med; 2013 Jul; 1(5):348-9. PubMed ID: 24429187
[No Abstract] [Full Text] [Related]
43. Acute tracheitis.
Heilman JA; Chandran SK; Sataloff RT
Ear Nose Throat J; 2010 Jul; 89(7):E39. PubMed ID: 20628980
[No Abstract] [Full Text] [Related]
44. Proton pump inhibitor failure--what are the therapeutic options?
Fass R
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
[TBL] [Abstract][Full Text] [Related]
45. Medical Therapy of GERD: current state of the art.
Johnson DA
Hosp Pract (1995); 1996 Oct; 31(10):135-9, 143-4, 147-8. PubMed ID: 8859212
[TBL] [Abstract][Full Text] [Related]
46. Treatment of gastroesophageal reflux disease: to step or not to step.
McGuigan JE
Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
[No Abstract] [Full Text] [Related]
47. [Characteristics of gastroesophageal reflux disease in elderly people].
Masharova AA; Bordin DS
Eksp Klin Gastroenterol; 2007; (4):37-40. PubMed ID: 18411443
[No Abstract] [Full Text] [Related]
48. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
Takenaka R; Okada H; Kawano S; Komazawa Y; Yoshinaga F; Nagata S; Inoue M; Komatsu H; Onogawa S; Kushiyama Y; Mukai S; Todo H; Okanobu H; Manabe N; Tanaka S; Haruma K; Kinoshita Y
World J Gastroenterol; 2016 Jun; 22(23):5430-5. PubMed ID: 27340360
[TBL] [Abstract][Full Text] [Related]
49. GERD: Diagnosing and treating the burn.
Alzubaidi M; Gabbard S
Cleve Clin J Med; 2015 Oct; 82(10):685-92. PubMed ID: 26469826
[TBL] [Abstract][Full Text] [Related]
50. Rebound acid hypersecretion.
McColl KE
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):201. PubMed ID: 15125688
[No Abstract] [Full Text] [Related]
51. Possibilities and shortcomings of maintenance therapy in gastroesophageal reflux disease.
Tytgat GN
Dig Surg; 1999; 16(1):1-6. PubMed ID: 9949259
[TBL] [Abstract][Full Text] [Related]
52. Prospective Study of Gastroesophageal Reflux, Use of Proton Pump Inhibitors and H2-Receptor Antagonists, and Risk of Hearing Loss.
Lin BM; Curhan SG; Wang M; Jacobson BC; Eavey R; Stankovic KM; Curhan GC
Ear Hear; 2017; 38(1):21-27. PubMed ID: 27556519
[TBL] [Abstract][Full Text] [Related]
53. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
[TBL] [Abstract][Full Text] [Related]
54. [Gastroesophageal reflux disease in pregnancy].
Nikolov A; Pevtichev S; Petrova D
Akush Ginekol (Sofiia); 2013; 52(7):35-40. PubMed ID: 24505639
[TBL] [Abstract][Full Text] [Related]
55. Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease.
Nakamura K; Akiho H; Ochiai T; Motomura Y; Higuchi N; Okamoto R; Matsui N; Yasuda D; Akahoshi K; Kabemura T; Ihara E; Harada N; Ito T; Takayanagi R
Hepatogastroenterology; 2010; 57(99-100):497-500. PubMed ID: 20698216
[TBL] [Abstract][Full Text] [Related]
56. [Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer].
Kashin SV; Ivanikov IO
Eksp Klin Gastroenterol; 2009; (2):90-8. PubMed ID: 19552026
[TBL] [Abstract][Full Text] [Related]
57. Antacid use and subclinical interstitial lung disease: the MESA study.
Restivo MD; Podolanczuk A; Kawut SM; Raghu G; Leary P; Barr RG; Lederer DJ
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28526800
[No Abstract] [Full Text] [Related]
58. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
Mine S; Iida T; Tabata T; Okada Y; Tanaka Y
J Gastroenterol Hepatol; 2008 Feb; 23(2):303-9. PubMed ID: 17725600
[TBL] [Abstract][Full Text] [Related]
59. [Optimal diagnosis and therapy of gastroesophageal reflux disease].
Ivanikov AA; Isakov VA; Maev IV
Ter Arkh; 2004; 76(2):71-5. PubMed ID: 15106421
[No Abstract] [Full Text] [Related]
60. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
Zacny J; Zamakhshary M; Sketris I; Veldhuyzen van Zanten S
Aliment Pharmacol Ther; 2005 Jun; 21(11):1299-312. PubMed ID: 15932360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
